Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gamelin

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumorsJ L Misset, E Gamelin, M Campone, et al.
Bulletin Du Cancer|January 1, 1996
[Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over]R Delva, M Mege, E Gamelin, et al.
Brain Research|June 10, 1996
Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microgliaC N Montero-Menei, L Sindji, E Garcion, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Early biotransformations of oxaliplatin after its intravenous administration to cancer patientsP Allain, O Heudi, A Cailleux, et al.
Journal De Chirurgie|December 1, 1995
[Implantable sites in cancerology. The percutaneous technique. Results of a homogeneous series of 141 cases]P Maillart, G Lorimier, V Meyer, et al.
Clinical Nuclear Medicine|May 16, 2001
False-positive suspicion of a thyroid metastatic lesion by In-111 pentetreotide uptake in a toxic nodular goiterM Gaci, O Morel, A M Sultan, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequencesM Boisdron-Celle, C Craipeau, S Brienza, et al.
Cancer Letters|October 27, 2006
5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiencyM Boisdron-Celle, G Remaud, S Traore, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding studyA Lortholary, P Maillard, R Delva, et al.
Journal of Oncology|April 17, 2010
Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal CancerC Louvet, T André, E Gamelin, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumorsJ L Misset, E Gamelin, M Campone, et al.
Bulletin Du Cancer|January 1, 1996
[Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over]R Delva, M Mege, E Gamelin, et al.
Brain Research|June 10, 1996
Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microgliaC N Montero-Menei, L Sindji, E Garcion, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Early biotransformations of oxaliplatin after its intravenous administration to cancer patientsP Allain, O Heudi, A Cailleux, et al.
Journal De Chirurgie|December 1, 1995
[Implantable sites in cancerology. The percutaneous technique. Results of a homogeneous series of 141 cases]P Maillart, G Lorimier, V Meyer, et al.
Clinical Nuclear Medicine|May 16, 2001
False-positive suspicion of a thyroid metastatic lesion by In-111 pentetreotide uptake in a toxic nodular goiterM Gaci, O Morel, A M Sultan, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequencesM Boisdron-Celle, C Craipeau, S Brienza, et al.
Cancer Letters|October 27, 2006
5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiencyM Boisdron-Celle, G Remaud, S Traore, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding studyA Lortholary, P Maillard, R Delva, et al.
Journal of Oncology|April 17, 2010
Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal CancerC Louvet, T André, E Gamelin, et al.
Pageof 8